Page 30 - ம்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ம்ப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ம்ப் Today - Breaking & Trending Today

Former employee files discrimination suit against North Myrtle Beach


Former employee files discrimination suit against North Myrtle Beach
In the lawsuit, the employee described unwanted touching that created a hostile work environment.
(Source: wmbf)
By Christian Boschult | April 23, 2021 at 8:04 PM EDT - Updated April 23 at 8:04 PM
Story courtesy of our news partners, MyHorryNews
A former employee of North Myrtle Beach’s finance department filed a lawsuit against the city on April 15, alleging in court records that she was terminated in retaliation for complaints about not being classified as a full-time worker despite working 40 hours a week.
Carolina Garcia, whose lawsuit describes her as a 46-year-old Hispanic woman with no religious affiliation, said she was hired in June 2016 as a part-time revenue business license inspector working 34-to-40 hours per week. ....

Pat Dowling , North Myrtle Beach , South Carolina , Grand Strand , Horry County , பேட் டௌலிஂக் , வடக்கு மிர்ட்டல் கடற்கரை ,

F. Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche's ENSPRYNG (satralizumab) for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD)


(0)
If approved, ENSPRYNG will be the first and only treatment available to both adults and adolescents from 12 years of age with anti-aquaporin-4 antibody (AQP4-IgG) seropositive NMOSD in the EU
ENSPRYNG is the only subcutaneous treatment option for NMOSD that can be administered at home every four weeks
Recommendation is based on results from the two pivotal Phase III
SAkuraStar
SAkuraSky
studies, in which ENSPRYNG demonstrated robust and sustained efficacy in reducing the risk of relapse and a
favourable
safety profile
NMOSD is a rare, lifelong and debilitating autoimmune disorder of the central nervous system that can cause blindness, muscle weakness and paralysis ....

United States , Nathalie Meetz , Jon Kaspar Bayard , Levi Garraway , Daniel Grotzky , Karl Mahler , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Loren Kalm , Lisa Tuomi , Patrick Barth , Karsten Kleine , European Medicines Agency , European Commission , Roche Group , Head Of Global Product Development , Committee For Medicinal Products Human Use , Roche Group Media Relations , Medicinal Products , Human Use , Chief Medical Officer , Global Product , ஒன்றுபட்டது மாநிலங்களில் , ஜான் காஸ்பர் வளைகுடா ,

Kimberly-Clark: Q1 Earnings Snapshot


Kimberly-Clark: Q1 Earnings Snapshot
FacebookTwitterEmail
DALLAS (AP) Kimberly-Clark Corp. (KMB) on Friday reported first-quarter net income of $584 million.
On a per-share basis, the Dallas-based company said it had profit of $1.72. Earnings, adjusted for restructuring costs, were $1.80 per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.90 per share.
The maker of consumer products such as Huggies diapers and Kleenex tissue posted revenue of $4.74 billion in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $4.94 billion.
Kimberly-Clark expects full-year earnings in the range of $7.30 to $7.55 per share. ....

Zacks Investment Research , Wall Street , Automated Insights , Zacks Investment , S Amp , Dallas Texas , United States , North America , Kimberly Clark , C Complete State National , 1 Earnings Snapshot , F Wire , Wall Street , Automated Insights , ஜாக்கக்ஸ் முதலீடு ஆராய்ச்சி , சுவர் தெரு , தானியங்கி நுண்ணறிவு , ஜாக்கக்ஸ் முதலீடு , கள் ஆம்ப் , எஃப் கம்பி , அனைத்தும் தெரு ,

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) Plus Yervoy (ipilimumab) as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma


Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) Plus Yervoy (ipilimumab) as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma
plus Yervoy
demonstrated significantly superior overall survival vs. standard-of-care chemotherapy
CheckMate -743 represents the first Phase 3 trial to show benefit with immunotherapy in previously untreated malignant pleural mesothelioma
If approved, Opdivo
plus Yervoy
will be the first new treatment option authorized for European patients that has demonstrated improved survival in more than 15 years
Bristol Myers Squibb (NYSE: BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of ....

United States , South Korea , Abderrahim Oukessou , Nina Goworek , Bristol Myers Squibb , Company Opdivo , Bristol Myers Squibb Company , European Union , Committee For Medicinal Products Human Use , Drug Administration , European Commission , Exchange Commission , Ono Pharmaceutical Co , European Medicines Agency , Myers Squibb , Medicinal Products , Human Use , Bristol Myers , Lung Cancer Virtual Presidential Symposium , International Association , Lung Cancer , Better Future , Fatal Immune Mediated Adverse , Full Prescribing Information , Allogeneic Hematopoietic Stem Cell , Multiple Myeloma ,

Kate Garraway shares good news on GMB that husband Derek Draper has talked


Thursday, April 22, 2021
Kate Garraway has told viewers the promising news her husband Derek Draper has spoken to her after coming home from his year-long stay in hospital battling Covid-19. 
Speaking about his progress on Good Morning Britain, Kate shared the warming exchange they had before she went to work. 
She said: It s been wonderful having Derek at home and lots of little positives, I think.
And whether those are positives because it is genuinely helping his cognition being at home or whether it s because I m there to see the little things.
Whereas I couldn t go in before and we were on Facetime and stuff. It feels positive, little moments of reaction. ....

United Kingdom , Kate Garraway , Derek Draper , Good Morning Britain , Virgin Radio , Kate Garraway , ஒன்றுபட்டது கிஂக்டம் , கேட் க்யாரவ , டெரெக் டிராப்பர் , நல்ல காலை பிரிட்டன் , கன்னி வானொலி ,